Source 1primary paper2025MED
Toolkit/logic-gated CAR-M circuits
logic-gated CAR-M circuits
Also known as: logic-gated circuits
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
sophisticated logic-gated circuits
Usefulness & Problems
Why this is useful
The abstract places logic-gated circuits within the molecular evolution of CAR-M designs. They are presented as an advanced receptor-design strategy in the CAR-M engineering landscape.; advanced CAR-M receptor design; intelligent receptor design
Source:
The abstract places logic-gated circuits within the molecular evolution of CAR-M designs. They are presented as an advanced receptor-design strategy in the CAR-M engineering landscape.
Source:
advanced CAR-M receptor design
Source:
intelligent receptor design
Problem solved
The review frames these circuits as part of intelligent receptor design for improving CAR-M therapy. The abstract does not specify the exact gating logic or performance tradeoffs.
Source:
The review frames these circuits as part of intelligent receptor design for improving CAR-M therapy. The abstract does not specify the exact gating logic or performance tradeoffs.
Problem links
The review frames these circuits as part of intelligent receptor design for improving CAR-M therapy
LiteratureThe review frames these circuits as part of intelligent receptor design for improving CAR-M therapy. The abstract does not specify the exact gating logic or performance tradeoffs.
Source:
The review frames these circuits as part of intelligent receptor design for improving CAR-M therapy. The abstract does not specify the exact gating logic or performance tradeoffs.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Target processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator
the molecular evolution of CAR-M designs, spanning from early constructs to sophisticated logic-gated circuits and innovative in vivo generation strategies utilizing lipid nanoparticles (LNPs)
the clinical translation of CAR-M faces several critical bottlenecks, including heterogeneity in cell sources, challenges in manufacturing standardization, risks of on-target/off-tumor toxicity, and the dynamic, immunosuppressive nature of the TME
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
CAR-M is presented as a promising next-generation therapeutic platform for solid tumors because macrophages have superior tumor-tropic migration, phagocytic capability, and capacity to remodel the tumor microenvironment.
macrophages - innate immune cells inherently poised within tissues - exhibit superior tumor-tropic migration, potent phagocytic capability, and a unique capacity to remodel the TME, establishing CAR-engineered macrophages (CAR-M) as a highly promising next-generation therapeutic platform
CAR-M design evolution described in the review spans early constructs, logic-gated circuits, and in vivo generation strategies using lipid nanoparticles.
the molecular evolution of CAR-M designs, spanning from early constructs to sophisticated logic-gated circuits and innovative in vivo generation strategies utilizing lipid nanoparticles (LNPs)
Clinical translation of CAR-M faces bottlenecks including cell-source heterogeneity, manufacturing standardization challenges, on-target off-tumor toxicity risk, and the dynamic immunosuppressive tumor microenvironment.
the clinical translation of CAR-M faces several critical bottlenecks, including heterogeneity in cell sources, challenges in manufacturing standardization, risks of on-target/off-tumor toxicity, and the dynamic, immunosuppressive nature of the TME
CAR-M antitumor mechanisms include a direct phagocytosis-presentation-activation cascade, synergy with immune checkpoint blockade, and deep reprogramming of the immunosuppressive tumor microenvironment.
the multimodal antitumor mechanisms of CAR-M, including the direct "phagocytosis-presentation-activation" cascade, synergistic potential with immune checkpoint blockade, and deep reprogramming of the immunosuppressive TME
Approval Evidence
1 source1 linked approval claimfirst-pass slug logic-gated-car-m-circuits
sophisticated logic-gated circuits
Source:
design evolutionsupports
CAR-M design evolution described in the review spans early constructs, logic-gated circuits, and in vivo generation strategies using lipid nanoparticles.
the molecular evolution of CAR-M designs, spanning from early constructs to sophisticated logic-gated circuits and innovative in vivo generation strategies utilizing lipid nanoparticles (LNPs)
Source:
Comparisons
Source-stated alternatives
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Source-backed strengths
presented as a sophisticated stage of CAR-M design evolution
Source:
presented as a sophisticated stage of CAR-M design evolution
Compared with CAR-engineered macrophages
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Compared with CAR-macrophages
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Compared with chimeric antigen receptor macrophage
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Compared with chimeric antigen receptor macrophages
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Compared with HER2-targeting CAR-M
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Compared with lipid nanoparticles
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Compared with mRNA-lipid nanoparticles
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Compared with mRNA-loaded lipid nanoparticles
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a sophisticated stage of CAR-M design evolution.
Source:
The abstract contrasts logic-gated circuits with early CAR-M constructs and with in vivo generation strategies using LNPs.
Ranked Citations
- 1.